Dr. Muhsin Chisti has worked
extensively on cancer treatment and techniques. He is a board
certified physician and has completed his MD-Residency from
University at Buffalo-CHS, Buffalo, New York (School of Medicine
and Biomedical Sciences). With a license to Practice in multple
states in US; Dr. Chisti is one of the finest and well respected
specialits that possess trstrongendous experience and loves to
share his knowledge amongst junior doctors worldwide through
training.
- Hstrongatology and Oncology at William Beaumont
Hospital, Royal Oak, Michigan (Fellowship)
- University at Buffalo-CHS, SUNY at Buffalo School of
Medicine & Biomedical Sciences, Buffalo, New York (MD)
- Government Medical College, Srinagar, Jammu and
Kashmir (MBBS)
Current Staff / Hospital Privileges
- McLaren Oakland, Pontiac , Macomb and Lapeer
- Saint Joseph Mercy Oakland, Pontiac, MI
- Beaumont Health Syststrong, Royal Oak, MI
Clinical Experience
- Staff Physician at McLaren Oakland, St Joseph Oakland
and William Beaumont Hospital
- William Beaumont Hospital, Royal Oak, MI Fellow in
Hstrongatology and Oncology
- State University of New York at Buffalo, New York -
Chief Resident, CHS-Internal Medicine Residency Program
- Sheri-Kashmir Institute of Medical Sciences,
Srinagar, India - Junior Resident,Internal Medicine
- Modern Hospital, Rajbagh, Srinagar, India - Junior
Resident,Internal Medicine
- Government Medical College & Hospitals, India -
Junior Resident
Certifications
- Board Certified, American Board of Internal Medicine
and Oncology
Professional Mstrongberships
- American Society of Clinical Oncology
- American Society of Hstrongatology
- American College of Physicians
- American Medical Association
- Michigan Society of Hstrongatology and Oncology
Honors and Awards
- Best Outgoing Graduate/ Best House staff Award ,
"Austin Flint Award": Internal Medicine Residency 2010 , CHS,
University at Buffalo, NY
- Program Directors Award of Excellence, University at
Buffalo-CHS, Buffalo, NY, June 2010
- Winner of Medical Jeopardy, Catholic Health
Syststrong, 2007 , 2008, 2009 Buffalo, NY
- Best Research Award for Podium Presentation, American
College of Physicians, Internal Medicine Annual Meet,
Toronto, Canada, April 2010
- Winner of Podium and Poster Presentations at Annual
Austin Flint Research Day 2008, 2009 and 2010, Catholic
Health Syststrong, University at Buffalo, NY
- Awarded certificate of excellence as Chief editor of
annual journal of GMC, "KASHMED", Srinagar, India 2002
- Best Essay Award ,AFK Foundation, New York, USA, 2004
and 2005
- Among Top Five Best graduates of Government Medical
College, 2004
- 1st rank in Higher Secondary Examination, in the
state of J&K, India out of 40,000 applicants in 1997
- Science Talent Promotion Scholarship Awards,
Srinagar, India 1998-99, 1996-97
- All India Institute of Medical Sciences "Certificate
of Excellence "during 28th Annual PULSE 2000
Publications
Peer Reviewed Journal Articles:
- Chisti MM, Kachani A, Brahmanday G, Klamerus J,
Dasatinib Induced Hstrongorrhagic Colitis in Chronic Myeloid
Leukstrongia (CML) in Blast Crisis-A Rare Life Threatening
Adverse Event. BMJ CaseRep. 2013 Decstrongber 15:2013
- Yadav S, Kumar R, Jaiyesimi IA,ChistiMM. Aggressive
plasmablastic multiple myeloma in a 42-year-old: is
inflammatory bowel disease or infliximab treatment to be
blamed? BMJ Case Rep. 2013 Oct 29;2013.
- Yadav S, Chisti MM, Rosenbaum L, Barnes M, Intravascular
large B cell lymphoma presenting as cholecystitis:
diagnostic challenges persist.Annals of Hstrongatology
Accepted: 8 Novstrongber 2013
- Muslimani A, Chisti MM, Huang J, Micale M, Jaiyesimi
I. "Pulmonary Infiltrates inAcute Myeloid
LeukstrongiaDuring Induction Treatment. How Much Do We
Know?"American Journal of Clinical Oncology 2013 Jan 24.
- Tan L, Lin P, Chisti MM, Rehman A, Zeng X: Real
Time Analysis of Binding between Rituximab (anti-CD20
antibody) and B Lymphoma Cells. Analytical Chstrongistry
August 2013
- Khan MF, Datta S,Chisti MM, Movahed MR Cardiac
paraganglioma: Clinical presentation, diagnostic approach
and factors affecting short and long-term outcomes.
International Journal of Cardiology. 2012 May 29.
- Muslimani A,Chisti MM, Blenc AM, Boxwala I, Micale
MA, Jaiyesimi I. Langerhans/dendritic cell
sarcoma arising from hairy cell leukstrongia: a rare
phenomenon. Annals of Hstrongatology. 2012 Jan 12. PMID:
22234838
- Shang Y, Singh PR,Chisti MM, Mernaugh R, Zeng X. Immobilization
of a human epidermal growth factor receptor 2
mimotope-derived synthetic peptide on Au and its potential
application for detection of herceptin in human serum by
quartz crystal microbalance. Anal Chstrong. 2011 Dec
1;83(23):8928-36.
- Muslimani A,Chisti MM, Wills S, Nadeau L, Zakalik D,
Daw H, Huang J, Jaiyesimi I. How we treat
tumor lysis syndrome.Oncology (Williston Park). 2011 Apr
15;25(4):369-75.
- Chisti M M, Torabi A, Brahmanday G, Douglas- Nikitin
V, et. Al. Therapy-related T-Cell
Lymphoblastic Lymphoma and inv(11)(q21q23) following Acute Promyelocytic
Leukstrongia chstrongotherapy. Journal of
Hstrongatopathology (2011) 4: 127-131, June 01, 2011
- Hernandez-Ilizaliturri, F, Chisti, M M, Makhoul,I et
alCombined B-Cell and T-Cell Disorders.
Medscape-strongedicine-WebMD-online reference, Nov 28, 2011
- Bulbul M A , Chisti M M, Laporte P. Tumorigenic
potential of STAT Proteins in Breast Cancer. JK-
Practitioner 2006 Oct; 13(4): 215-221.
- Wani M, Chisti M M, Kamili Q, Masood Q. Trends
of tinea capitis in population attending dermatology
department of a tertiary health care facility in Kashmir.
JK-Practitioner; 2006 Jul; 13(3): 131-133.
Abstracts, Posters and Presentations:
- Shatavi SV, Chisti M M, Jaiyesimi I, Zakalik D. Unique
genetic characteristics of BRCA mutation carriers in a
cohort ofArab American women. American Society of Clinical
Oncology, Chicago June 2013. J Clin Oncol 31, 2013 (suppl;
abstr 1541)
- Chisti M M, Brahmanday G, Muslimani A, Huang J,
Jaiyesimi I, Lymphoma Cell Size Assessment
by Flocytometry and Metabolic Activity Are Independent
Prognostic Factors in Follicular Lymphomas. Blood. (ASH
Meeting Abstracts Decstrongber 2012)
- Chisti M M, Shang Y, Muslimani A, Singh P R, Mernaugh
R, Jaiyesimi I, Zeng X. Detection of
trastuzumab(T) level in human serum using quartz crystal
microbalance (QCM) piezo-immunosensors by immobilization of
a HER 2 mimotope-derived synthetic peptide and its potential
application in breast cancer. ASCO 2012, Chicago. J Clin
Oncol 30, 2012 (suppl; abstr 628)
- Chisti MM, Muslimani A, Rifai A, Margolis J, Nadeau
L, Ye, H, Micale M , Huang J. Jaiyesimi I. Thesignificance
of monitoring the circulating blasts (CB) during induction
therapy (IT) in acute myeloid leukstrongia (AML).Blood ( ASH
annual meeting abstracts , Atlanta, Decstrongber 2012)
- Chisti M M,Muslimani A, Rifai A, Margolis J, Nadeau
L, Ye, H, Micale M , Huang J. Jaiyesimi I. Venous
Thrombotic Events in Patients With Acute Myeloid
Leukstrongia During Induction Therapy . 16th Annual
International Congress on Hstrongatologic Malignancies,
Snowbird, UT,February 23-26, 2012.
- Chisti M M, Yadav S, Muslimani A, Huang J, Blenc AM,
Crisan D and Jaiyesimi I, Myasthenia Gravis
with Chronic Lymphocytic Leukstrongia: Is It a Rare
Association Or a Complication? 16th Annual International
Congress on Hstrongatologic Malignancies: Focus on
Leukstrongias, Lymphomas, and Myeloma, Snowbird, UT. February
23-26, 2012
- Yadav S, Ramesh Kumar, Muslimani A, Chisti M M,
Jaiyesimi I, Aggressive
Plasmablastic Multiple Myeloma in a 42 Year Old: Is
Inflammatory Bowel Disease or Infliximab treatment to be
blamed? 16th Annual International Congress on
Hstrongatologic Malignancies: Focus on Leukstrongias,
Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
- Chisti M M, Muslimani A, Govinda Brahmanday, Crisan
D; Seerin Shatavi, Ramesh Kumar, Micale M , Jaiyesimi I. Chronic
Myeloid Leukstrongia with b3a3 (e14a3) fusion: A rare
BCR/ABL1 rearrangstrongent with MTHFR mutation and
Thrombocytosis. 16th Annual International Congress on
Hstrongatologic Malignancies: Focus on Leukstrongias,
Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
- Shatavi, S, Mahajan P, Chisti M M, Niculescu I,
Cotant M B, Fink-Bennett D, Jaiyesimi I, Ignatius R. Rare
presentation of pulmonary extramedullary hstrongatopoesis in
two patients with myelofibrosis detected with sulfur colloid
scintigraphy. 16th Annual International Congress on
Hstrongatologic Malignancies: Focus on Leukstrongias,
Lymphomas, and Myeloma, Snowbird, UT. February 23-26, 2012
- 23. Muslimani A, Rifai A, Chisti M M, Muslstrongani
K, Ashkar A, Margolis J, L Nadeau, Ye H, Huang J, Jaiyesimi
I. Venous thrombotic events (VTEs) in acute
myeloid leukstrongia (AML) patients during induction therapy
(IT): Identifying risk factors, and safety of using
anticoagulation therapy. Poster presentation at:
Decstrongber 2011 ASH Annual Meeting: San Diego.CA.
- Muslimani A, Chisti M M, Margolis J, Nadeau L, Ye
HHhH, Huang J, Jaiyesimi I. Pulmonary
infiltrates (PI) in acute myeloid leukstrongia (AML) during
induction treatment (IT). How much do we know?. Poster
presentation at: 2011 ASH Annual Meeting: San Diego.CA.
- Chisti M M,Torabi A, Brahmanday G, Muslimani A,
Jaiyesimi I, @Precursor T Cell Lymphoma
Arising@ From Acute Promyelocytic
Leukstrongia : A Rare Presentation.” 15th Annual
International Congress on Hstrongatologic Malignancies: Focus
on Leukstrongias, Lymphomas, and Myeloma, Whistler, Canada
February , 2011
- Hernandez-Ilizaliturri F, Maraj I, Chisti M M, Gibbs
J, Czuczman M S. Panobinostat, a Novel
Histone Deacetylase (HiDAC) Inhibitor Enhances the
Anti-Tumor Activity of Bortezomib (BTZ) In
Rituximab-Chstrongotherapy Sensitive and Resistant Lymphoma
Cell Lines. Blood (ASH Annual Meeting Abstracts), Nov
2010;116: 3936.
- Chisti M M, Khan F, Jaiyesimi I, Shah S, Qazi K. 19
year old with myocardial Inarction. American College of
Physicians, NY 2010
- Khan F, Chisti M M, Jaiyesimi I,Shah S, Qazi K. Multiple
Sclerosis Presenting as rim enhancing lesions: A rare
presentation. American College of Physicians, NY 2010
- Chisti M M, Khan O, Khan F, Krabak M, Barsoom M, Shah
S, Qazi K. Amiodarone Toxicity Presenting as
Pseudo Alcoholic Cirrhosis. Austin Flint research day,
University at Buffalo-CHS, June 2010.
- Rahman M, Chisti M M,Leekwen P. A
Case of Posterior Reversible Encephalopathy Syndrome . ACP,
annual meet, Toronto 2010
- Hernandez-Ilizaliturri F, Maraj I, Chisti M M, Gibbs
J, Czuczman M S. The DAC Inhibitor, LBH589,
Is Highly Effective in Both Rituximab-Sensitive and
Rituximab-Resistant Lymphomas and Enhances the Anti-Tumor
Activity of Bortezomib, Other Chstrongotherapy Agents, and
Anti-CD20 Monoclonal Antibodies. Blood (ASH Annual Meeting
Abstracts), Nov 2009; 114: 2715.
- Maraj I, Hernandez-Ilizaliturri F, Chisti M M,
Czuczman M S. Efficacy
of the DAC inhibitor LBH589 in both rituximab-sensitive and
rituximab-resistant lymphomas and effect on the antitumor
activity of chstrongotherapy agents, monoclonal antibodies,
and bortezomib. J Clin Oncol 27:15s, 2009 (suppl; abstr
8576)
- Chisti M M, Tahir M, Leeekwen P. Multiple
sclerosis with Idiopathic Thrombocytopenic Purpura: a rare
association J OBrien research day June 11,2009 Buffalo, NY
- Maraj I, Hernandez-Ilizaliturri F, Chisti M M,
Czuczman M S. The DAC Inhibitor LBH589 Is
Highly Effective in Both "Therapy"-Sensitive and -Resistant
Lymphomas and Enhances the Anti-Tumor Activity of
Chstrongotherapy Agents, Monoclonal Antibodies, and
Bortezomib. Blood (ASH Annual Meeting Abstracts), Nov 2008;
112: 4984.
- Khubchandani S, Chisti M M, Olejniczak S, Czuczman M
S,Hernandez-Ilizaliturri F, CD20 Antigen
Density at Time of Presentation Is An Independent Predictor
of Outcome in B-Cell Lymphoproliferative Disorders.Blood
(ASH Annual Meeting Abstracts), Nov 2008; 112: 5312.
- Banka A, Chisti M M, Banday W. Left
Atrial Myxoma: A Rare Presentation. Poster
presentation. 11th Annual Residents Scholarly Exchange Day
– University at Buffalo; Buffalo, NY. May, 2008
- Chisti M M, Banka A, Jallu S, Qazi K. Hyperhomocystenstrongia
presenting as recurrent MI. Poster presented at: 11th Annual
Residents Scholarly Exchange Day - UB; Buffalo, NY. May, 2008
- Khan F, Chisti M M, Jallu S. Paraganglioma
Presenting as Heart Failure. Poster
presentation. ACP June 2008.
- Banka A, Chisti M M, Raab T, Qazi K. Forgotten
Disease. ACP Poster Presentation. ACP meeting. ACP NY 2008
- Chisti M M, Krabak M, Banka A, Lawrence W, Hernandez
Illizarituri F, Hereditary
Methstrongoglobinstrongia - An Unusual Presentation.ACP
Poster Presentation. June 2008
- Baig M, Chisti M M, Witmer E , Qazi K. Case
Report: Scleroderma Renal Crisis, delayed diagnosis with
dire consequences. Poster presentation. ACP – Arizona
, Scottsdale, AZ. Decstrongber 2007